Pemetrexed Enhances Anti-Tumor Efficacy of PD-L1 blockade by Promoting Intra-Tumor Immune Response via Tumor and T Cell-Intrinsic Mechanisms

被引：2

作者：

Schaer, D. ^{[1
]}

Geeganage, S. ^{[2
]}

Amaladas, N. ^{[1
]}

Lu, Z. H. ^{[2
]}

Rasmussen, E. ^{[1
]}

Sonyi, A. ^{[1
]}

Chin, D. ^{[1
]}

Capen, A. ^{[2
]}

Li, Y. ^{[1
]}

Meyer, C. ^{[2
]}

Jones, B. ^{[1
,2
]}

Huang, X.

Luo, S. ^{[2
]}

Carpenito, C. ^{[1
]}

Roth, K. ^{[2
]}

Nikolayev, A. ^{[2
]}

Tan, B. ^{[2
]}

Brahmachary, M. ^{[1
]}

Chodavarapu, K. ^{[1
]}

Dorsey, F. ^{[2
]}

Manro, J. ^{[2
]}

Doman, T. ^{[2
]}

Donoho, G. ^{[2
]}

Hall, G. ^{[1
]}

Kalos, M. ^{[1
]}

Novosiadly, R. ^{[1
]}

机构：

[1] Eli Lilly, New York, NY USA

[2] Eli Lilly, Indianapolis, IN USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

pemetrexed; PD-(L)1; chemoimmunotherapy;

D O I：

10.1016/j.jtho.2018.08.722

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.04-07

引用

页码：S527 / S527

页数：1

共 50 条

[1] Pemetrexed enhances anti-tumor efficacy of PD1 pathway blockade by promoting intra tumor immune response via immunogenic tumor cell death and T cell intrinsic mechanisms
Novosiadly, Ruslan
Schaer, David
Amaladas, Nelusha
Rasmussen, Erik
Lu, Zhao Hai
Sonyi, Andreas
Carpenito, Carmine
Li, Yanxia
Luo, Shuang
Capen, Andrew
Meyer, Catalina
Huang, Xiaodong
Manro, Jason
Donoho, Gregory
Doman, Thompson
Hall, Gerald
Geeganage, Sandaruwan
Kalos, Michael
CANCER RESEARCH, 2018, 78 (13)
[2] Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models
Li, Yanxia
Amaladas, Nelusha
O'Mahony, Marguerita
Manro, Jason R.
Inigo, Ivan
Li, Qi
Rasmussen, Erik R.
Brahmachary, Manisha
Doman, Thompson N.
Hall, Gerald
Kalos, Michael
Novosiadly, Ruslan
Puig, Oscar
Pytowski, Bronislaw
Schaer, David A.
PLOS ONE, 2022, 17 (07):
[3] PD-L1 blockade enhances anti-tumor efficacy of NK cells
Oyer, Jeremiah L.
Gitto, Sarah B.
Altomare, Deborah A.
Copik, Alicja J.
ONCOIMMUNOLOGY, 2018, 7 (11):
[4] Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models
Kandaswamy, Veena
Forest, Amelie
Deroose, Marianne
Schaer, David A.
Chen, Ting
Liu, Shengwu
Surguladze, David
Yao, Yung-mae
Doman, Thompson
Hall, Gerald
Wong, Kwok-Kin
Kalos, Michael
Novosiadly, Ruslan D.
CANCER RESEARCH, 2018, 78 (13)
[5] PD-L1 plays a B cell-intrinsic role in suppressing the antibody response and anti-tumor immunity.
Cervantes, Christian
Khan, Mustafa
Fernandez, Maria
Liu, Zexuan
Hakeem, Zainab
Viswanadhapalli, Suryavathi
Gupta, Harshita B.
Curiel, Tyler J.
Yan, Hui
Vadlamudi, Ratna
Xu, Zhenming
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[6] SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Ye Wang
Morvarid Mohseni
Angelo Grauel
Javier Estrada Diez
Wei Guan
Simon Liang
Jiyoung Elizabeth Choi
Minying Pu
Dongshu Chen
Tyler Laszewski
Stephanie Schwartz
Jane Gu
Leandra Mansur
Tyler Burks
Lauren Brodeur
Roberto Velazquez
Steve Kovats
Bhavesh Pant
Giri Buruzula
Emily Deng
Julie T. Chen
Farid Sari-Sarraf
Christina Dornelas
Malini Varadarajan
Haiyan Yu
Chen Liu
Joanne Lim
Huai-Xiang Hao
Xiaomo Jiang
Anthony Malamas
Matthew J. LaMarche
Felipe Correa Geyer
Margaret McLaughlin
Carlotta Costa
Joel Wagner
David Ruddy
Pushpa Jayaraman
Nathaniel D. Kirkpatrick
Pu Zhang
Oleg Iartchouk
Kimberly Aardalen
Viviana Cremasco
Glenn Dranoff
Jeffrey A. Engelman
Serena Silver
Hongyun Wang
William D. Hastings
Silvia Goldoni
Scientific Reports, 11
[7] SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Wang, Ye
Mohseni, Morvarid
Grauel, Angelo
Diez, Javier Estrada
Guan, Wei
Liang, Simon
Choi, Jiyoung Elizabeth
Pu, Minying
Chen, Dongshu
Laszewski, Tyler
Schwartz, Stephanie
Gu, Jane
Mansur, Leandra
Burks, Tyler
Brodeur, Lauren
Velazquez, Roberto
Kovats, Steve
Pant, Bhavesh
Buruzula, Giri
Deng, Emily
Chen, Julie T.
Sari-Sarraf, Farid
Dornelas, Christina
Varadarajan, Malini
Yu, Haiyan
Liu, Chen
Lim, Joanne
Hao, Huai-Xiang
Jiang, Xiaomo
Malamas, Anthony
LaMarche, Matthew J.
Geyer, Felipe Correa
McLaughlin, Margaret
Costa, Carlotta
Wagner, Joel
Ruddy, David
Jayaraman, Pushpa
Kirkpatrick, Nathaniel D.
Zhang, Pu
Iartchouk, Oleg
Aardalen, Kimberly
Cremasco, Viviana
Dranoff, Glenn
Engelman, Jeffrey A.
Silver, Serena
Wang, Hongyun
Hastings, William D.
Goldoni, Silvia
SCIENTIFIC REPORTS, 2021, 11 (01)
[8] Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances antitumor efficacy of PD-L1 blockade in syngeneic murine tumor models
Li, Yanxia
Schaer, David
O'Mahony, Marguerita
Inigo, Ivan
Li, Qi
Amaladas, Nelusha
Rasmussen, Erik
Doman, Thompson
Manro, Jason
Murphy, Mary
Francisco, Macrina
Hall, Gerald
Kalos, Michael
Novosiadly, Ruslan
Pytowski, Bronislaw
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[9] Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
Munoz, Luis Enrique
Huang, Lei
Bommireddy, Ramireddy
Sharma, Richa
Monterroza, Lenore
Guin, Rohini N.
Samaranayake, Sarah G.
Pack, Christopher D.
Ramachandiran, Sampath
Reddy, Shaker J. C.
Shanmugam, Mala
Selvaraj, Periasamy
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
[10] NKG2A immune checkpoint blockade enhances the anti-tumor efficacy of PD1/PD-L1 inhibitors in a preclinical model
Sola, Caroline
Arnoux, Thomas
Chanuc, Fabien
Fuseri, Nicolas
Rossi, Benjamin
Gauthier, Laurent
Leget, Corinne
Bonnafous, Cecile
Wagtmann, Nicolai
Morel, Yannis
Andre, Pascale
CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →